Multifield optimization intensity-modulated proton therapy (MFO-IMPT) for prostate cancer: Robustness analysis through simulation of rotational and translational alignment errors

Journal Article · Tue Oct 01 00:00:00 EDT 2013 · Medical Dosimetry

DOI:https://doi.org/10.1016/J.MEDDOS.2013.03.007· OSTI ID:22262833

Amos, Richard A. ^[1]; John Baptiste, Sandra; Choi, Seungtaek; Nhu Nguyen, Quyhn ^[2]; Ronald Zhu, X. ^[1]; Palmer, Matthew B.; Lee, Andrew K. ^[2]

---

1. Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX (United States)
2. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX (United States)

To evaluate the dosimetric consequences of rotational and translational alignment errors in patients receiving intensity-modulated proton therapy with multifield optimization (MFO-IMPT) for prostate cancer. Ten control patients with localized prostate cancer underwent treatment planning for MFO-IMPT. Rotational and translation errors were simulated along each of 3 axes: anterior-posterior (A-P), superior-inferior (S-I), and left-right. Clinical target-volume (CTV) coverage remained high with all alignment errors simulated. Rotational errors did not result in significant rectum or bladder dose perturbations. Translational errors resulted in larger dose perturbations to the bladder and rectum. Perturbations in rectum and bladder doses were minimal for rotational errors and larger for translational errors. Rectum V45 and V70 increased most with A-P misalignment, whereas bladder V45 and V70 changed most with S-I misalignment. The bladder and rectum V45 and V70 remained acceptable even with extreme alignment errors. Even with S-I and A-P translational errors of up to 5 mm, the dosimetric profile of MFO-IMPT remained favorable. MFO-IMPT for localized prostate cancer results in robust coverage of the CTV without clinically meaningful dose perturbations to normal tissue despite extreme rotational and translational alignment errors.

• OSTI ID: 22262833
• Journal Information: Medical Dosimetry, Vol. 38, Issue 3; Other Information: Copyright (c) 2013 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0958-3947
• Country of Publication: United States
• Language: English

Related Subjects

61 RADIATION PROTECTION AND DOSIMETRY
BLADDER
ERRORS
NEOPLASMS
OPTIMIZATION
PROSTATE
PROTON BEAMS
RADIATION DOSES
RECTUM
THERAPY